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1. Introduction 
In recent years there has been considerable interest 
in the enhanced metabolism of phosphatidyl inositol 
(PI) which may be observed in a wide variety of tissues 
in response to physiological stimuli [l] . Such enhanced 
metabolism is often first detected as an increase in 
the rate of incorporation of inorganic phosphate into 
PI, which is frequently accompanied by a similar effect 
upon phosphatidic acid. It has been suggested that 
these results reflect enhanced turnover of PI, with the 
stimulus acting to enhance the breakdown of PI to 
1,2-diacylglycerol within the plasma membrane [l] . 
The ubiquity of enhanced PI turnover in response to 
various stimuli suggests that the phenomenon may be 
fundamentally implicated in the cellular responses to 
such stimuli. For example, recent evidence suggests 
that enhanced PI breakdown may be intrinsic to the 
mechanism of the muscarinic choline@ receptor 
PI. 
As part of a study concerning the short-termd 
influences of hormones upon hepatic metabolism, 
this paper reports the effects of vasopressin, adrenaline 
and glucagon upon the incorporation of inorganic 
phosphate into PI. These three hormones exert similar 
effects upon hepatic metabolism, enhancing glycogeno- 
lysis and gluconeogenesis in the perfused liver [3,4] 
and glycogenolysis in isolated hepatocytes [5-71. 
There is general agreement hat glucagon and 
P-adrenergic agonists exert their metabolic effects 
upon the liver by elevating the intracellular concentra- 
tion of adenosine 3’,5’-cyclic monophosphate [3,8]. 
Neither a-adrenergic agents nor vasopressin elevate 
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hepatic cyclic AMP [8,9], and their mechanisms of 
action remain obscure. However recent evidence 
suggests that Ca2+ may be involved [6,7] . The 
possibility that enhanced PI metabolism may have a 
role in the control of hepatic metabolism by these 
hormones merits consideration. The experiments 
described in this paper were designed as a first approach 
to testing this hypothesis. 
2. Materials and methods 
2.1. Preparation and incubation of hepatocytes 
Isolated hepatocytes were prepared from fed male 
Wistar rats (200 g) by perfusion of the liver with 
collagenase [lO,l l] . The original method was modified 
in the following ways: 
(i) Hyaluronidase was omitted from the Ca2’-free 
perfusion medium, which contained collagenase 
(0.5 mglml). 
(ii) After perfusion, the step which involved further 
shaking in a flask was omitted. 
The yield of hepatocytes was 3-5 g from livers that 
normally weighed about 9 g. The viability of the hepa- 
tocyte suspensions was monitored in several ways, 
including microscopic examination to check that most 
cells had intact plasma membranes and did not form 
clusters. Trypan blue was excluded by about 95% of 
the cells in all suspensions used in the present study. 
The hepatocyte preparations exhibited glycogen con- 
centrations similar to those observed in vivo (200-300 
~01 glucose/g wet liver). Also, vasopressin induced 
glycogenolysis at lower concentrations of hormone 
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than are effective in the perfused liver (Whitton and 
Hems, unpublished results). 
Hepatocytes were incubated in plastic scintillation 
vials at 37°C in a shaking water bath. Each vial con- 
tained 10-l 5 mg dry cells in 2 ml bicarbonate- 
buffered saline [ 121 containing 2% w/v bovine serum 
albumin (fraction V) and 30-500 &i [32P]- 
phosphate. Hormones and dihydroergotamine were 
added to the vials in 0.01 ml water, and the solutions 
were freshly prepared each day. Pre-warmed hepato- 
cyte suspensions were added at zero time to vials 
containing [32P]phosphate and hormones at 37°C. 
Incubations were terminated with the addition of 
0.2 mls 80% (w/v) trichloracetic acid (TCA). For 
each cell preparation, the dry wt cells/ml incubation 
medium was determined in duplicate. 
2.2. Analytical techniques 
At the end of the incubation period, the TCA 
precipitate was collected by centrifugation and 
extracted for 2 h with 10 ml chloroform:methanol: 
HC1(66:33:0.25) at 37°C in a shaking water bath. The 
extract was filtered under vacuum and the residue 
washed once with 10 ml chloroform:methanol:HCl 
(66:33:0.25). This lipid extract was then evaporated 
to dryness in a heated sand bath under a stream of N2. 
Phospholipids were separated by two dimensional 
thin-layer chromatography (t.1.c.) on 0.5 mm plates 
of silica gel G prepared in 0.01 M Na2C03 [ 131. The 
developing solvents were chloroform:methanol:acetic 
acid:water (125:75:19:3) followed by chloroform: 
methanol:4 M NH40H (75:37:7). The plates were left 
to dry in a stream of air for 30 mins between solvents, 
Triacylglycerols have an RF of nearly 1 .O in both 
solvent systems, and consequently did not interfere 
with-the separation of the major hepatic phospholipids. 
These phospholipids were identified with the help of 
commercially available pure standard samples. PI, for 
use as a chromatographic standard, was prepared by 
solvent fractionation of a crude extract of ovine 
cephalin [ 141. 
The separated phospholipids were visualised in I2 
vapour and their positions were marked on the plate. 
When the I2 on the plate had resublimed, the spots 
were scraped into scintillation vials containing 10 ml 
scintillant (8 g/litre butyl PBD in toluene). The radio- 
activity of the separated phospholipids was determined 
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together with that of samples of incubation medium 
in an LKB 1210 Ultrobeta liquid scintillation counter. 
The efficiency of counting was calculated by means 
of a channels ratio quench correction technique. In 
some experiments, the radioactivity of total lipid 
phosphorus was determined in the chloroform: 
methanol:HCl extracts prior to separation of individ- 
ual phospholipids by t.1.c. The results of these 
experiments indicated that there was an 85% recovery 
of total lipid phosphorus following the t.1.c. procedure 
described above. 
2.3, Chemicals 
L-Adrenaline bitartrate, [8-arginine] vasopressin, 
dihydroergotamine tartrate and phospholipid standards 
were from Sigma Chemical Co., and glucagon was 
kindly donated by Eli-Lilly Ltd. Collagenase (Grade II) 
was from C. F. Boehringer Corp. Ltd and bovine serum 
albumin (fraction V) was supplied by Miles Lab. Ltd. 
[32P] Orthophosphate was from the Radiochemical 
Centre, Amersham. All other chemicals were of the 
highest grade commercially available. 
3. Results 
3.1. The effects of hormones upon PI metabolism 
The incorporation of inorganic phosphate into PI 
was stimulated in hepatocyte suspensions exposed 
for 20 min to vasopressin (10 mu/ml) or adrenaline 
(2 X lo-’ M), but not in suspensions exposed to 
glucagon (low6 M) table 1). Vasopressin treatment 
resulted in a 7-fold stimulation of phosphate 
incorporation into PI, whilst the effect of adrenaline 
treatment was less than 2-fold. The effects of these 
two hormones were also tested in the presence of 
dihydroergotamine (2.5 X lo-’ M), when adrenaline 
failed to influence phosphate incorporation into PI, 
but the stimulation by vasopressin of this process was 
undiminished. Hepatocyte suspensions treated with 
dihydroergotamine (2.5 X lo-’ M) alone exhibited 
rates of phosphate incorporation into PI similar to 
those in control suspensions. The basal rates of 
phosphate incorporation into both PI and total 
hepatic phospholipids were similar to those observed 
in vivo [ 151 and in hepatocyte suspensions [ 161. 
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Table 1 
The effects of various hormones upon the incorporation of inorganic 
phosphate into hepatic PI 
Hormone addition Incorporation of phosphate into PI 
(ng atom/g dry wt/20 min) 
None 
Vasopressin (10 mu/ml) 
Adrenaline (2 X IOs5 M) 
Glucagon ( 10d6 M) 
Dihydroergotamine (2.5 X 1O‘5 M) 
Adrenaline (2 X 10“ M) 
6.6 f 1.2 (5) 
47.8 + 5.3 (7)a 
12.2 f 1.0 (6)a 
5 .O + 0.6 (4) 
3.6 +_ 0.5 (5) 
+ Dihydroergotamine (2.5 X 10e5 M) 
Vasopressin ( 10 mu/ml) 
3.6 + 0.7 (5) 
+ Dihydroergotamine (2.5 X lo-’ M) 69.2 f 7.7 (3)a 
ap versus hormone-free controls, < 0.01 
Hepatocytes were prepared and incubated for 20 min, in the presence of 5 mM 
glucose, as described in the text. Results are expressed as means f SEM of the 
number of observations in parentheses, which were from three separate hepatocyte 
preparations 
3.2. The time course of basal and vasopressin- 
stimulated phosphate incorporation into 
hepatic phospholipids 
The rate of incorporation of [32P]phosphate into 
both PI and total phospholipids in the absence of 
exogenous hormones increased over a period of 60 
min (fig.1). This increase may reflect a gradual rise in 
the specific radioactivity of inorganic phosphate 
within the cell. The vasopressin-induced stimulation of 
phosphate incorporation into PI was about 4-6-fold 
at all times tested, while that into total phospholipids 
was 2-3-fold. The vasopressin-stimulated rates of 
phosphate incorporation into PI remained significantly 
greater than the control rates at all times (p < 0.01). 
The results of experiments designed to elucidate 
the effect of vasopressin upon the incorporation of 
Fig.1. Time course of phosphate incorporation into hepatic 
phospholipids. Hepatocytes were prepared without added 
glucose, and incubated as described in the text. Incubations 
were performed in the presence of vasopressin (10 mu/ml, 
closed symbols) and in hormone-free conditions (open 
symbols). The radioactivity was determined, and phosphate 
incorporation calculated in total phospholipids (= 0) and in 
PI isolated by t.1.c. (0 0). Each point represents the 
mean f SEM of at least five determinations from three 
separate hepatocyte preparations. 
November 1977 
Time (min) 
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Table 2 
The early effects of vasopressin upon phosphate 
incorporation into hepatic PI 
Incubation Vasopressin Incorporation of 
time concentration phosphate into PI 
(mm) (mU/ml) (pg atom/g dry wt) 
2 0 41+ 8 
2 10 376 + 133a 
5 0 447 +_ 92 
5 10 2172 k 354a 
10 0 1249 r 447 
10 10 5310* 1729a 
a p versus hormone-free controls, < 0.0 1 
Hepatocytes were prepared without added glucose and 
incubated as described in the text. Hormones and [‘*PI- 
phosphate were present throughout the incubation period. 
Results are means f SEM five determinations from these 
separate hepatocyte preparations 
inorganic phosphate into PI after brief periods of 
exposure to the hormone are shown in table 2. After 
2 min exposure to the hormone, the incorporation of 
inorganic phosphate into PI was 9 times that observed 
in hormone-free suspensions. After 5 min and 10 min 
exposure, the hormone exerted 5- and 4-fold effects, 
respectively. In all cases, the hormone-stimulated rate 
of phosphate incorporation was significantly greater 
than that in hormone-free conditions @ < 0.01). 
4. Discussion 
It is evident from these results that the hormones 
vasopressin and adrenaline exert a rapid and profound 
effect upon the rate at which inorganic phosphate is 
incorporated into hepatic PI. The observation that 
adrenaline but not glucagon enhances phosphate 
incorporation into PI is in agreement with the results 
of an earlier study using liver slices [ 171, which also 
reported that this effect of adrenaline was abolished 
in the presence of dihydroergotamine. The dihydro- 
ergotamine sensitivity of the adrenaline-stimulated 
process, which was also demonstrated in the present 
study, suggests that the enhanced incorporation of 
phosphate into PI observed in the presence of 
adrenaline may be classified as an a-adrenergic 
response. The vasopressin-stimulated process 
270 
remained insensitive to dihydroergotamine, indicating 
that these two hormones stimulate PI synthesis via 
different receptors. 
PI constitutes only about 9% of total hepatic 
phospholipids [ 181 and the basal incorporation of 
exogenous [32P]phosphate into PI was also about 9% 
of that into total lipids (fig.1). However, under vaso- 
pressin-stimulated conditions, the incorporation of 
[32P]phosphate into PI accounted for about 50% of 
that incorporated into total phospholipids. In fact, 
the total increment in phosphate incorporation into 
all hepatic phospholipids following vasopressin treat- 
ment could be accounted for by the enhanced incor- 
poration into PI. Further evidence in favour of this 
conclusion emerged in the same experiments as those 
described in fig.1, in which vasopressin did not sig- 
nificantly influence phosphate incorporation into 
phosphatidyl choline, lysophosphatidyl choline, 
sphingomyelin, phosphatidyl ethanolamine or phos- 
phatidyl serine (Kirk, C. J. and Verrinder, T. R. 
unpublished results). Thus the stimulation by vaso- 
pressin of phosphate incorporation into PI cannot 
merely be the result of enhanced inorganic phosphate 
transfer across the plasma membrane, or of increased 
incorporation of the isotope into intermediates of 
phospholipid synthesis, such as ATP. 
The stimulation of inorganic phosphate incorpora- 
tion into PI was greatest after the briefest period of 
exposure to the hormone which was tested (2 min, 
table 2). In this respect the stimulation of PI synthesis 
by vasopressin is similar to the stimulation of hepatic 
cyclic AMP production by glucagon, in that a maximal 
effect occurs within a very short time of exposure to 
the hormone [3]. The observation that vasopressin 
enhances PI synthesis within 2 min establishes this 
effect as one of the most rapid upon PI metabolism 
which has yet been reported. This maximal effect of 
vasopressin in the present study coincides with the 
maximal stimulation of glycogen phosphorylase activ- 
ity and with the rapid onset of Ca2+ uptake in vaso- 
pressin-treated hepatocytes [7]. The fact that these 
responses to the hormone occur simultaneously could 
imply the existence of a functional relationship 
between them. 
It has been suggested that PI turnover plays a role 
in the coupling between receptor activation and 
enhanced membrane permeability to Ca’+ in smooth 
muscle [2,19,20]. It is probable that the results of 
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the present study reflect enhanced turnover of PI 
(although the data do not exclude net synthesis). The 
cleavage of the glyceryl-phosphate bond in PI is 
catalysed by an enzyme in the plasma membrane, (at 
least in the brain: [20,21]). Thus this reaction is a 
suitable candidate for direct stimulation by receptor- 
agonist interaction in tissue plasma membrane. The 
influence of vasopressin and adrenaline upon this 
reaction remains to be established, 
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